
March 6 (Reuters) - Wegovy maker Novo Nordisk NOVOb.CO plans to sell its weight-loss drugs on Hims & Hers Health HIMS.N platform, bringing an end to a dispute between the two companies that escalated into a legal battle last month, Bloomberg News reported on Friday.
Novo and Hims plan to announce a new partnership as soon as Monday, the report said, citing a person familiar with the matter.